Dr. Ayalon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
725 Albany St
Ste A
Boston, MA 02118Phone+1 617-414-8680Fax+1 617-638-7326- Is this information wrong?
Education & Training
Boston University Medical CenterFellowship, Nephrology, 2009 - 2011
Ben Gurion University of the NegevClass of 1999- Ben-Gurion UniversityB.Med.Sc., 1992 - 1995
Certifications & Licensure
MA State Medical License 2013 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Career Development Fellowship Award Nephrotic Syndrome Study Network (NEPTUNE), 2012
- Graduated in excellence Medical Internship, Sheba (Tel-Hashomer) Medical Center, 2000
Publications & Presentations
PubMed
- 27 citationsMembranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R eraLuisa Safar-Boueri, Albina Piya, Laurence H. Beck, Rivka Ayalon> ;Pediatric Nephrology. 2021 Jan 1
- 19 citationsPregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case ReportLaith Al-Rabadi, Rivka Ayalon, Ramon G. Bonegio, Jennifer E. Ballard, Alan M. Fujii, Joel Henderson, David J. Salant, Laurence H. Beck> ;American Journal of Kidney Diseases. 2016 May 1
- 43 citationsPre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transpla...Gaurav Gupta, Hasan Fattah, Rivka Ayalon, Jason M. Kidd, Todd W.B. Gehr, Luis F. Quintana, Pamela Kimball, Salima Sadruddin, H. Davis Massey, Dhiren Kumar, Anne L. Kin...> ;Clinical Transplantation. 2016 Apr 1
- Join now to see all
Journal Articles
- Anti-Phospholipase A(2) Receptor Antibodies and Malignancy in Membranous NephropathyTimmermans SA, Ayalon R, van Paassen P, Beck Jr LH, van Rie H, Wirtz JJ, Verseput GH, Frenken LA, Salant DJ, Cohen Tervaert JW, Am J Kidney Dis, 9/7/2013
- Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathyWada Y, Saeki T, Yoshita K, Ayalon R, Kamimura K, Nakano M, Narita I, Clin Kidney J, 1/1/2013
- Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A2 receptor antibody-positive membranous nephropathySurindran S, Ayalon R, Hasan N, Beck LH, Salant DJ, Barisoni L, Skolnik EY, Beara-Lasic L, Clin Kidney J, 1/1/2012
- Join now to see all
Abstracts/Posters
- Anti-PLA2R-Associated Membranous Nephropathy in Adolescents and Young AdultsBeck LH, Ayalon R, Trachtman H, Salant DJ, American Society of Nephrology, Annual Meeting, 1/1/2012
- Perez NS, Ayalon R, Arcal C, Beck LH Jr , Campistol JM, Salant DJ, Quintana LF, American Society of Nephrology, Annual Meeting, 1/1/2012
- Prevalence of anti-PLA2R autoantibodies in pediatric patients with Idiopathic Membranous Nephropathy (IMN)Trachtman H, Sethna C, Frank R, Infante L, Ayalon R, Beck LH, Salant DJ, American Society of Pediatric Nephrology, PAS Annual Meeting, 1/1/2012
- Join now to see all
Lectures
- Do Anti-Phospholipase A2 Receptor Antibodies Predict Recurrence of Membranous Nephropathy after Transplantation?1/1/2012
- A Pilot Study to Determine Dose, Effectiveness and Depletion of Anti- PLA2R Antibodies of Adrenocorticotrophic Hormone (ACTH Acthar Gel) in Subjects with Nephrotic Syn...1/1/2012
Hospital Affiliations
Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
